Skip to main content
. 2018 Nov 8;21(6):1295–1307. doi: 10.1038/s41436-018-0330-z

Table 1.

Clinical characteristics of ARID1B patients

Total ARID1B-CSS ARID1B-ID
Clinical featuresd n= 143 % n =79 % n =64 % p value Test
Sex (female) 143 48.3 79 57.0 64 37.5 0.028 a
Growth parameters & development
 Gestational age, weeks (mean; SD) 133 39.0; 2.1 75 39.1; 2.0 58 38.9; 2.4 0.879 b
 Birthweight (<–2 SDS) 129 5.4 74 6.8 55 3.6 0.506 c
 Height at birth (<–2 SDS) 43 9.3 27 11.1 16 6.3 0.660 c
 OFC at birth (<–2 SDS) 51 3.9 35 2.9 16 6.3 0.232 c
 Age last measurements, years (median; min–max) 143 10; 0–51 79 10; 0–36 64 9; 0.5–51 0.682 b
 Weight (<–2 SDS) 92 6.5 46 8.7 46 4.3 0.571 c
 Height (<–2 SDS) 122 30.3 70 37.1 52 21.2 0.177 c
 OFC (<–2 SDS) 105 2.9 63 3.2 42 2.4 0.670 c
 Motor skills gross, delayed 103 99.0 46 97.8 57 100.0 0.447 c
 Motor skills fine, delayed 100 95.0 44 97.7 56 92.9 0.381 c
 Speech, delayed 131 65.6 75 68.0 56 62.5 0.106 c
 Obstructive sleep apneae 71 8.5 34 0.0 37 16.2 0.026 c
 Laryngomalaciae 90 19.8 47 17.0 44 22.7 0.466 a
 Feeding difficulties 121 69.4 62 62.9 59 76.3 0.111 a
 Start of feeding difficulties 71 34 37 0.345 c
   Birth 76.1 76.5 75.7
   Before 6 months 16.9 20.6 13.5
   After 6 months 7.0 2.9 10.8
 Duration of feeding problems 58 23 35 0.639 c
   Brief 46.6 39.1 51.4
   Several years 6.9 8.7 5.7
   Ongoing 46.6 52.2 42.9
Tube feeding 65 16.9 22 13.6 43 18.6 0.409 c
   0–6 months 10.8 4.5 14.0
   6–12 months 3.1 4.5 2.3
   1–3 years 1.5 0.0 2.3
 Recurrent infections 75 57.3 30 63.3 45 53.3 0.391 a
   Upper airway tract 17.3 10.0 22.2
   Lower airway tract 2.7 0.0 4.4
   ENT infections 12.0 10.0 13.3
   Otitis media 14.7 13.3 15.6
   Urinary tract 2.7 3.3 2.2
Neurological features
 Intellectual disability 127 99.2 70 98.6 57 100.0 0.015 c
   Normal–mild 3.1 1.4 5.3
   Mild 28.3 38.6 15.8
   Mild–moderate 15.7 8.6 24.6
   Moderate 22.0 22.9 21.1
   Moderate–severe 16.5 17.1 15.8
   Severe 13.4 10.0 17.5
 Hypotonia 116 81.0 71 80.3 45 82.2 0.795 a
Seizures 142 27.5 78 28.2 64 26.6 0.880 c
   No seizures, but abnormal EEG 5.6 6.4 4.7
Seizure frequency 18 9 9 0.671 c
   Once 27.8 11.1 44.4
   Less than once a year 11.1 22.2 0.0
   Once a year 33.3 44.4 22.2
   Once a month 11.1 11.1 11.1
   1/2 a month 5.6 0.0 11.1
   ≥2 per month 5.6 0.0 11.1
Agenesis of the corpus callosum 101 28.7 62 29.0 39 28.2 0.344 c
   Partial/hypoplasia 13.9 17.7 7.7
Neuroradiology 47 87.2 17 94.1 30 83.3 0.305 a
   Delayed myelination 17.0 11.8 20.0
   Mega cisterna magna 14.9 23.5 10.0
   Colpocephaly 10.6 11.8 10.0
   Hypoplasia 4.3 0.0 6.7
   Enlarged Virchow–Robin spaces 4.3 5.9 3.3
Vision and hearing impairments
Vision impaired 109 48.6 62 45.2 47 53.2 0.406 a
Vision problems 68 70.6 33 78.8 35 62.9 0.320 c
   Astigmatism 16.2 24.2 8.6
   Strabismus 30.9 36.4 25.7
   Optic nerve hypoplasia 2.9 6.1 0.0
   Nystagmus 8.8 6.1 11.4
   Refraction error 10.3 9.1 11.4
Myopia 102 27.5 59 18.6 43 39.5 0.020 a
Hypermetropia 50 18.0 21 28.6 29 10.3 0.140 c
Abnormal eye exam 40 17.5 15 6.7 25 24.0 0.224 c
Hearing loss 122 22.1 71 18.3 51 27.5 0.157 a
   Hearing loss, conductive 6.6 1.4 13.7
   Hearing loss, bilateral 11.5 8.5 15.7
   Hearing loss, unilateral 4.9 5.6 3.9
   Eartubes 4.9 4.2 5.9
Start hearing problems, congenital 11 63.6 3 66.7 8 62.5 0.109 c
Hearing aid 5 80.0 2 100.0 3 66.7 0.665 c
Dysmorphic features
Coarse face 121 81.8 62 90.3 59 72.9 0.013 a
Hairline (low anterior and/or posterior) 91 69.2 45 75.6 46 63.0 0.196 a
Scalp hair, abnormal 129 79.1 78 83.3 51 72.5 0.141 a
   Sparse 58.1 62.8 51.0
Forehead (broad or narrow) 95 42.1 49 28.6 46 56.5 0.000 c
   Broad 22.1 6.1 39.1
   Narrow 20.0 22.4 17.4
Eyelashes, long 131 63.4 79 75.9 52 44.2 0.000 a
Eyebrows, thick 134 81.3 78 91.0 56 67.9 0.001 a
Ptosis 133 20.3 77 20.8 56 19.6 0.872 a
Tear duct nonfunctioning or absent 93 15.1 54 16.7 39 12.8 0.609 a
Nasal bridge, abnormal 100 61.0 59 62.7 41 58.5 0.050 a
   Wide 34.0 40.7 24.4
   Flat 21.0 20.3 22.0
   Broad 12.0 5.1 22.0
Nasal tip, abnormal 129 76 53 0.002 a
   Broad 58.1 61.8 52.8
   Upturned (anteverted nares) 29.5 39.5 15.1
Nose, abnormal 83 47.0 43 53.5 40 40.0 0.022 a
   Short 26.5 39.5 12.5
   Long 20.5 14.0 27.5
Alae nasi, thick 107 55.1 69 66.7 38 34.2 0.001 a
Nasal base, broad 88 48.9 48 43.8 40 55.0 0.392 a
Philtrum, abnormal 109 78.9 72 86.1 37 64.9 0.001 a
   Short 24.8 29.2 16.2
   Long 44.0 48.6 35.1
   Broad 34.9 44.4 16.2
Mouth, large 131 68.7 75 76.0 56 58.9 0.037 a
Upper vermillion, abnormal 127 56.7 75 60.0 52 51.9 0.366 a
   Thin 35.4 45.3 21.2
   Thick 21.3 14.7 30.8
Lower vermillion, thick 125 69.6 76 78.9 49 55.1 0.005 a
Lower lip, drooping 71 56.3 30 76.7 41 41.5 0.004 a
Cleft palate/submucous cleft 90 6.7 35 14.3 55 1.8 0.031 a
   Cleft palate 2.2 5.7 0.0
   Bifid uvula 2.2 5.7 0.0
   Submucous cleft 3.3 5.7 1.8
High arched palate 85 16.5 31 22.6 54 13.0 0.250 a
Ears, abnormal 122 52.5 66 57.6 56 46.4 0.433 a
   Low-set 9.8 13.6 5.4
   Posterior rotated 7.4 9.1 5.4
Hypertrichosis 128 86.7 76 94.7 52 75.0 0.001 a
Musculoskeletal anomalies
Scoliosis 123 26.0 70 27.1 53 24.5 0.743 a
Pectus, excavatum 104 13.5 57 14.0 47 12.8 0.850 a
Primary dentition, delayed 65 44.6 40 50.0 25 36.0 0.313 a
Permanent dentition, delayed 33 48.5 18 33.3 15 66.7 0.056 a
Widely spaced teeth 72 41.7 40 40.0 32 43.8 0.748 a
Bone age, delayed 40 47.5 30 46.7 10 50.0 1.000 c
Joint laxity 88 60.2 52 61.5 36 58.3 0.763 a
Early arthritis 75 5.3 36 5.6 39 5.1 1.000 c
Clinodactyly 77 36.4 42 45.2 35 25.7 0.076 a
Short phalanges 49 34.7 34 41.2 15 20.0 0.151 a
Complete absent or small 5th distal phalanx 110 40.0 66 60.6 44 9.1 0.000 c
Prominent distal phalanges; 102 24.5 64 31.3 38 13.2 0.040 a
Prominent interphalangeal joints 103 21.4 64 28.1 39 10.3 0.032 a
Brachydactyly general 60 16.7 19 15.8 41 17.1 1.000 c
Brachydactyly fifth finger 68 30.9 22 50.0 46 21.7 0.018 a
Small nails 122 54.9 73 68.5 49 34.7 0.000 a
Which nails, 5th finger and/or toe 106 55.7 67 65.7 39 38.5 0.007 a
Which nails, all 53 11.3 29 20.7 24 0.0 0.027 c
Fetal finger pads 100 29.0 50 26.0 50 32.0 0.509 a
Intestinal
Inguinal hernia 90 7.8 46 2.2 44 13.6 0.056 c
Intestinal problems 105 48.6 60 36.7 45 64.4 0.000 a
   Constipation 30.5 21.7 42.2
   Gastroesophageal reflux 17.1 13.3 22.2
   Diarrhea 4.8 3.3 6.7
   Pyloric Stenosis 2.9 5.0 0.0
   Umbilical hernia 4.8 1.7 8.9
Cardiac & genitourinary anomalies
Cardiac anomalies 113 19.5 69 21.7 44 15.9 0.492 a
   ASD 10.6 13.0 6.8
   VSD 5.3 5.8 4.5
Renal anomalies 95 12.6 53 11.3 42 14.3 0.666 c
Renal sonography, abnormal 43 25.6 19 21.1 24 29.2 0.105 c
Cryptorchidism 65 55.4 28 39.3 37 67.6 0.023 a
Endocrinological abnormalities e
Diabetes mellitus 71 7.0 43 7.0 28 7.1 1.000 c
Type 2 diabetes mellitus 4 75.0 2 100.0 2 50.0 1.000 c
Age (years) diagnosis (min–max) 2 18–46 1 18.0 1 46.0 0.317 b
Hypothyroidism 63 19.0 38 15.8 25 24.0 0.417 a
Age (years) diagnosis (median; min–max) 10 8; 1–40 4 4; 1.3–36.0 6 6; 1.0–40.0 0.394 b
Growth hormone deficiency 51 13.7 33 18.2 18 5.6 0.398 c
Growth hormone supplementation 50 12.0 31 16.1 19 5.3 0.387 c
Behavioral characteristics
Behavioral abnormalities 71 83.1 28 85.7 43 81.4 0.945 a
   Hyperkinetic 15.5 14.3 16.3
   Short attention 25.4 25.0 25.6
   Impulsiveness 14.1 14.3 14.0
   Obsessive 15.5 14.3 16.3
   Rigid 8.5 3.6 11.6
   Anger outbursts 16.9 10.7 20.9
   Aggressive 16.9 14.3 18.6
   Anxious 23.9 17.9 27.9
   Poor sociability 19.7 17.9 20.9
Hyperactivity 63 42.9 25 60.0 38 31.6 0.026 a
High pain thresholde 47 40.4 28 28.6 19 57.9 0.044 a
Psychiatric disorders
ADHD 48 33.3 16 50.0 32 25.0 0.083 a
Autistic traits 77 57.1 27 66.7 50 52.0 0.215 a
Malignancies 97 1.0 53 0.0 44 2.3 0.454 c

Only characteristics present in ≥5% of all patients or in either patient group, characteristics differing between groups, and distinctive features are shown.

ADHD attention deficit hyperactivity disorder, ARID1B-CSS patient group with a suspicion of Coffin–Siris syndrome before genetic testing, ARID1B-ID patient group with no suspicion of Coffin–Siris syndrome before genetic testing, ASD atrial septal defect, CSS Coffin–Siris syndrome, EEG electroencephalography, ENT ear nose throat, OFC occipitofrontal circumference, SDS standard deviation score, VSD ventricular septal defect.

aChi-square.

bMann–Whitney U.

cFisher’s.

dThe total number of a feature can differ from the sum of subcategories, because in some cases it was possible to answer with more than one option or to report the existence of a feature without specifying.

eData regarding these features were collected through email after first analyses.